These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 22701550)

  • 1. Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals.
    Song F; Poljak A; Crawford J; Kochan NA; Wen W; Cameron B; Lux O; Brodaty H; Mather K; Smythe GA; Sachdev PS
    PLoS One; 2012; 7(6):e34078. PubMed ID: 22701550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma apolipoproteins and physical and cognitive health in very old individuals.
    Muenchhoff J; Song F; Poljak A; Crawford JD; Mather KA; Kochan NA; Yang Z; Trollor JN; Reppermund S; Maston K; Theobald A; Kirchner-Adelhardt S; Kwok JB; Richmond RL; McEvoy M; Attia J; Schofield PW; Brodaty H; Sachdev PS
    Neurobiol Aging; 2017 Jul; 55():49-60. PubMed ID: 28419892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly.
    Slot RE; Van Harten AC; Kester MI; Jongbloed W; Bouwman FH; Teunissen CE; Scheltens P; Veerhuis R; van der Flier WM
    J Alzheimers Dis; 2017; 56(2):687-697. PubMed ID: 28035918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.
    Montañola A; de Retana SF; López-Rueda A; Merino-Zamorano C; Penalba A; Fernández-Álvarez P; Rodríguez-Luna D; Malagelada A; Pujadas F; Montaner J; Hernández-Guillamon M
    Neuromolecular Med; 2016 Mar; 18(1):99-108. PubMed ID: 26661731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between serum leptin levels, lipid profiles and neurocognitive deficits in Chinese OSAHS patients.
    Peng Y; Zhou L; Cao Y; Chen P; Chen Y; Zong D; Ouyang R
    Int J Neurosci; 2017 Nov; 127(11):981-987. PubMed ID: 28117613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship Between Plasma Aβ Levels, Cognitive Function and Brain Volumetrics: Sydney Memory and Ageing Study.
    Poljak A; Crawford JD; Smythe GA; Brodaty H; Slavin MJ; Kochan NA; Trollor JN; Wen W; Mather KA; Assareh AA; Ng PC; Sachdev PS
    Curr Alzheimer Res; 2016; 13(3):243-55. PubMed ID: 26679856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ApoE and clusterin CSF levels influence associations between APOE genotype and changes in CSF tau, but not CSF Aβ42, levels in non-demented elderly.
    Slot RER; Kester MI; Van Harten AC; Jongbloed W; Bouwman FH; Teunissen CE; Scheltens P; van der Flier WM; Veerhuis R
    Neurobiol Aging; 2019 Jul; 79():101-109. PubMed ID: 31029938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High density lipoprotein and its apolipoprotein-defined subspecies and risk of dementia.
    Koch M; DeKosky ST; Goodman M; Sun J; Furtado JD; Fitzpatrick AL; Mackey RH; Cai T; Lopez OL; Kuller LH; Mukamal KJ; Jensen MK
    J Lipid Res; 2020 Mar; 61(3):445-454. PubMed ID: 31892526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging.
    Gupta VB; Doecke JD; Hone E; Pedrini S; Laws SM; Thambisetty M; Bush AI; Rowe CC; Villemagne VL; Ames D; Masters CL; Macaulay SL; Rembach A; Rainey-Smith SR; Martins RN;
    Alzheimers Dement (Amst); 2016; 3():18-26. PubMed ID: 27239546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ApoJ/Clusterin concentrations are determinants of cerebrospinal fluid cholesterol efflux capacity and reduced levels are associated with Alzheimer's disease.
    Ko YA; Billheimer JT; Lyssenko NN; Kueider-Paisley A; Wolk DA; Arnold SE; Leung YY; Shaw LM; Trojanowski JQ; Kaddurah-Daouk RF; Kling MA; Rader DJ
    Alzheimers Res Ther; 2022 Dec; 14(1):194. PubMed ID: 36572909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between Alcohol Consumption and HDL Subspecies Defined by ApoC3, ApoE and ApoJ: the Cardiovascular Health Study.
    Wilkens TL; Sørensen H; Jensen MK; Furtado JD; Dragsted LO; Mukamal KJ
    Curr Probl Cardiol; 2023 Jan; 48(1):101395. PubMed ID: 36096454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher Apolipoprotein C-III Levels in Cerebrospinal Fluid are Associated with Slower Cognitive Decline in Mild Cognitive Impairment.
    Wang Q; Zhou W; Zhang J;
    J Alzheimers Dis; 2019; 67(3):961-969. PubMed ID: 30689582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between cognitive impairment and apolipoprotein A1 or apolipoprotein B levels is regulated by apolipoprotein E variant rs429358 in patients with chronic schizophrenia.
    Rao W; Zhang Y; Li K; Zhang XY
    Aging (Albany NY); 2021 Jun; 13(12):16353-16366. PubMed ID: 34135129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum Apolipoprotein B with cerebrospinal fluid biomarkers of Alzheimer's pathology.
    Hu H; Tan L; Bi YL; Xu W; Tan L; Shen XN; Hou XH; Ma YH; Dong Q; Yu JT
    Ann Clin Transl Neurol; 2020 Oct; 7(10):1766-1778. PubMed ID: 32910550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease.
    Soares HD; Potter WZ; Pickering E; Kuhn M; Immermann FW; Shera DM; Ferm M; Dean RA; Simon AJ; Swenson F; Siuciak JA; Kaplow J; Thambisetty M; Zagouras P; Koroshetz WJ; Wan HI; Trojanowski JQ; Shaw LM;
    Arch Neurol; 2012 Oct; 69(10):1310-7. PubMed ID: 22801723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Apolipoprotein E in Lipoprotein Subspecies With Risk of Dementia.
    Koch M; DeKosky ST; Goodman M; Sun J; Furtado JD; Fitzpatrick AL; Mackey RH; Cai T; Lopez OL; Kuller LH; Mukamal KJ; Jensen MK
    JAMA Netw Open; 2020 Jul; 3(7):e209250. PubMed ID: 32648923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. apoA2 correlates to gestational age with decreased apolipoproteins A2, C1, C3 and E in gestational diabetes.
    Ramanjaneya M; Butler AE; Bashir M; Bettahi I; Moin ASM; Ahmed L; Elrayess MA; Hunt SC; Atkin SL; Abou-Samra AB
    BMJ Open Diabetes Res Care; 2021 Mar; 9(1):. PubMed ID: 33674281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtypes Based on Six Apolipoproteins in Non-Demented Elderly Are Associated with Cognitive Decline and Subsequent Tau Accumulation in Cerebrospinal Fluid.
    Zou S; Zhang J; ; Chen W
    J Alzheimers Dis; 2019; 72(2):413-423. PubMed ID: 31594221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
    Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.